Altamira Therapeutics Establishes OTC Consumer Health Business Unit

3 years ago

Dedicated unit to support Altamira's activities in consumer health productsOTC Consumer Health to be led by experienced marketing strategist, Jean…

Bayer Discontinues Clinical Development Candidate Eliapixant (BAY1817080), Evotec Regains the Rights to all P2X3 Assets

3 years ago

HAMBURG, GERMANY / ACCESSWIRE / February 4, 2022 / Evotec SE (Frankfurt Stock Exchange, MDAX/TecDAX, ISIN: DE 000 566480 9,…

StageZero Life Sciences Announces Warrant Extension

3 years ago

TORONTO, ON / ACCESSWIRE / February 4, 2022 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), a vertically…

Nass Valley Gardens Inc. Announces It Will File to Launch a Reg A+ Public Offering

3 years ago

WEST PALM BEACH, FL, Feb. 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nass Valley Gardens Inc., a Nevada registered…

ICU Medical Announces Time of Fourth Quarter 2021 Earnings Conference Call

3 years ago

SAN CLEMENTE, Calif., Feb. 04, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and…

Shockwave Medical to Participate in the SVB Leerink 11th Annual Global Healthcare Conference

3 years ago

SANTA CLARA, Calif., Feb. 04, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of…

Alimera Sciences to Present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Investor Conference

3 years ago

ATLANTA, Feb. 04, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is…

SomaLogic Provides 2022 Revenue Guidance in Conjunction with Analyst and Investor Meeting

3 years ago

BOULDER, Colo., Feb. 04, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, will host a…

Revolo Biotherapeutics Receives MHRA Approval for Two Phase 2 Clinical Trials of ‘1805 in Autoimmune Diseases in the United Kingdom

3 years ago

Company to initiate one Phase 2 trial in rheumatoid arthritis and a second Phase 2 trial in uveitisNEW ORLEANS and…

Surgery Partners, Inc. Announces Fourth Quarter 2021 Earnings Release Date and Conference Call Details

3 years ago

BRENTWOOD, Tenn., Feb. 04, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical…